Cozzolino MG - Search Results

1

Proposal for a New Classification of Solutes of Interest in Uremia and Hemodialysis.

Kashani K, Cozzolino MG, Massy ZA, Blankestijn PJ, Stenvinkel P, Rosner MH, Ronco C. Kashani K, et al. Among authors: cozzolino mg. Blood Purif. 2023;52(3):233-241. doi: 10.1159/000528040. Epub 2022 Dec 9. Blood Purif. 2023. PMID: 36502799 Review.

2

CCN2 (CTGF) gene polymorphism is a novel prognostic risk factor for cardiovascular outcomes in hemodialysis patients.

Cozzolino M, Biondi ML, Banfi E, Riser BL, Mehmeti F, Cusi D, Gallieni M. Cozzolino M, et al. Blood Purif. 2010;30(4):272-6. doi: 10.1159/000320706. Epub 2010 Nov 11. Blood Purif. 2010. PMID: 21071938

3

Mineral metabolism abnormalities and vitamin D receptor activation in cardiorenal syndromes.

Ronco C, Cozzolino M. Ronco C, et al. Heart Fail Rev. 2012 Mar;17(2):211-20. doi: 10.1007/s10741-011-9232-8. Heart Fail Rev. 2012. PMID: 21327712 Review.

4

The impact of paricalcitol on left ventricular hypertrophy.

Cozzolino M, Ronco C. Cozzolino M, et al. Contrib Nephrol. 2011;171:161-165. doi: 10.1159/000327170. Epub 2011 May 23. Contrib Nephrol. 2011. PMID: 21625106 Review.

5

Role of vitamin d receptor activators in cardio-renal syndromes.

Cozzolino M, Bruschetta E, Stucchi A, Ronco C, Cusi D. Cozzolino M, et al. Semin Nephrol. 2012 Jan;32(1):63-9. doi: 10.1016/j.semnephrol.2011.11.009. Semin Nephrol. 2012. PMID: 22365164 Review.

6

Vitamin D metabolites and/or analogs: which D for which patient?

Mazzaferro S, Goldsmith D, Larsson TE, Massy ZA, Cozzolino M. Mazzaferro S, et al. Curr Vasc Pharmacol. 2014 Mar;12(2):339-49. doi: 10.2174/15701611113119990024. Curr Vasc Pharmacol. 2014. PMID: 23713876 Review.

7

Vitamin K1 to slow vascular calcification in haemodialysis patients (VitaVasK trial): a rationale and study protocol.

Krueger T, Schlieper G, Schurgers L, Cornelis T, Cozzolino M, Jacobi J, Jadoul M, Ketteler M, Rump LC, Stenvinkel P, Westenfeld R, Wiecek A, Reinartz S, Hilgers RD, Floege J. Krueger T, et al. Nephrol Dial Transplant. 2014 Sep;29(9):1633-8. doi: 10.1093/ndt/gft459. Epub 2013 Nov 26. Nephrol Dial Transplant. 2014. PMID: 24285427 Clinical Trial.

8

Is chronic kidney disease-mineral bone disorder (CKD-MBD) really a syndrome?

Cozzolino M, Ureña-Torres P, Vervloet MG, Brandenburg V, Bover J, Goldsmith D, Larsson TE, Massy ZA, Mazzaferro S; CKD-MBD Working Group of ERA-EDTA. Cozzolino M, et al. Nephrol Dial Transplant. 2014 Oct;29(10):1815-20. doi: 10.1093/ndt/gft514. Epub 2014 Feb 9. Nephrol Dial Transplant. 2014. PMID: 24516228 Free article.

9

Bone: a new endocrine organ at the heart of chronic kidney disease and mineral and bone disorders.

Vervloet MG, Massy ZA, Brandenburg VM, Mazzaferro S, Cozzolino M, Ureña-Torres P, Bover J, Goldsmith D; CKD-MBD Working Group of ERA-EDTA. Vervloet MG, et al. Among authors: cozzolino m. Lancet Diabetes Endocrinol. 2014 May;2(5):427-36. doi: 10.1016/S2213-8587(14)70059-2. Lancet Diabetes Endocrinol. 2014. PMID: 24795256 Review.

10

Achievement of NKF/K-DOQI recommended target values for bone and mineral metabolism in incident hemodialysis patients: results of the FARO-2 cohort.

Cozzolino M, Messa P, Brancaccio D, Cannella G, Bolasco P, Di Luca M, Costanzo AM, Paparatti Ud, Festa V, Gualberti G, Mazzaferro S; FARO Study Group. Cozzolino M, et al. Blood Purif. 2014;38(1):37-45. doi: 10.1159/000365386. Epub 2014 Sep 27. Blood Purif. 2014. PMID: 25277167 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

279 results

Search Page

Filters